Following up from my note yesterday, I'll be blunt: I'm not sure why anyone would want to miss out on this.. Dear Reader, Following up from my note yesterday, I'll be blunt: I'm not sure why anyone would want to miss out on this... But if you don't act by tomorrow, you will. That's when my good friend [Dr. David "Doc" Eifrig's charter membership for Prosperity Investor]( will expire forever. Now, after nearly 15 years at Stansberry Research – and more than four decades in the markets as an investing pro – he stepped forward with the most important (and highest potential upside) research of his life. The culmination of everything he's ever done – inside and outside of finance. And the work he says will remain his legacy decades from now. If you haven't seen Doc's huge announcement yet (plus your special invitation) – [see it right here](. I guarantee it will be worth your time today, even if you never spend a penny on new research. It's heartfelt... personal... and quite fascinating. What Doc reveals could affect your health and well-being (as well as your wealth) for years to come. More important, the opportunity Doc is sharing could: - Help you [compound your wealth by 25% per year in low-risk, recession- and inflation-proof "Forever Stocks"...]( - And show you gains as high as 1,000% in the coming years in a handful of emerging technology stocks driving the complete transformation of health care. That combination of upside and low risk is extraordinary in today's market. For example, in 2008, when the S&P 500 fell by 38%... one of Doc's new recommendations was up 11%. Another was up 7%. [And now it's happening again](. The Nasdaq has fallen about 25% since November... But one of Doc's new "Forever Stock" recommendations has gained as much as 25% over the exact same period. This is what he had to say about it: "If this was the only stock you owned for the last 20 years – you won – a 20-bagger in that time... And I see NO reason why it's not another 10-bagger over the next decade!" And just one more thing you might not have heard about yet... Because I really don't want you to miss this: [One of Doc's brand-new recommendations pays a near 9% dividend yield today](. Meaning it essentially wipes out all the effects of inflation just for owning it. And that's before the potential capital upside... in a business that millions of Americans will have pretty much no choice but to use in the coming years. I've known Doc for more than a decade... He's always had a steady hand through every market crisis. And he's one of the top-performing analysts at Stansberry Research. While he's never been big on making predictions, this is something altogether different... [Doc doesn't hold anything back in this presentation](. And why should he? He's speaking from nearly half a century of expertise. This is his wheelhouse. His life's work. Best of all, Doc's giving away a FREE bonus year of this research... PLUS five new research reports... two exclusive video presentations... and a lot more. But I'm told all of that ends tomorrow... and this offer will not be repeated. [Until tomorrow, access your invitation right here](. Regards, Sam Latter
Editor in Chief, Empire Financial Research --------------------------------------------------------------- All contents of this e-mail are copyright 2022 by Empire Financial Research. All rights reserved. Reproducing any part of this document is prohibited without the express written consent of Whitney Tilson. Protected by U.S. Copyright Law {Title 17 U.S.C. Section 101 et seq., Title 18 U.S.C. Section 2319}: Infringements can be punishable by up to five years in prison and $250,000 in fines. DISCLAIMER: The work included in this publication is based on SEC filings, current events, interviews, and corporate press releases. It may contain errors, and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility. The views expressed in this publication do not necessarily reflect the views of Empire Financial Research. You're receiving this email at {EMAIL}. If you have any questions about your subscription, or would like to change your email settings, please contact Empire Financial Research at (800) 961-2618 (US) or (646) 609-8709 (international) Monday-Friday between 9:00 a.m. and 5:00 p.m. Eastern Time. Empire Financial Research, 601 Lexington Ave, 20th Floor New York, NY 10022. If you wish to contact us by email, please do not reply to this message but instead go to info@empirefinancialresearch.com. To unsubscribe from email messages like these, please [click here](.